Braman Family Breast Cancer Institute
Dean Pascal J. Goldschmidt, M.D., University of Miami President Donna E. Shalala, Norman and Irma Braman, Joseph Rosenblatt, M.D., and Joyce Slingerland, M.D., Ph.D., gather for the ribbon cutting at the new Braman Family Breast Cancer Institute research headquarters.
History & Overview
Building of the Institute
A generous gift from the Norman and Irma Braman Family Foundation made the Braman Family Breast Cancer Institute at Sylvester a reality in 2002. The Bramans’ initiative has garnered considerable and continued support from the community, helping to fuel our progress in the fight against breast cancer.
Recruited to lead the initiative and state-of-the-art institute is renowned breast cancer physician-scientist Joyce M. Slingerland, M.D., Ph.D., director of the Braman Family Breast Cancer Institute at Sylvester. Much of the success of the Braman Institute can be attributed to the work and leadership of director Dr. Slingerland, clinical director Mark D. Pegram, M.D., research associate director Zafar Nawaz, Ph.D., and associate clinical director Eli Avisar, M.D.
Recognizing the power and promise of the Braman Institute’s effort, in 2005, the State of Florida awarded a generous allocation to fund breast cancer research at Sylvester, and provided additional funding to expand its community outreach and patient education activities. The Braman Institute and the Women’s Health Institute at the University of Miami are driving the activities of the Breast Cancer Education Program, aimed at reaching out to the underprivileged population.
What’s more, as a result of the ongoing multidisciplinary basic science that our researchers are conducting, Institute members have been awarded a number of highly competitive grants from the National Cancer Institute. In addition, the Braman Institute was recognized as an independent program for breast cancer by Sylvester in 2009. The breast cancer program, co-led by Dr. Slingerland and Dr. Pegram, is composed of more than 30 faculty members from multiple departments, enhancing our research collaborative activities. The program receives more than $11 million per year in new, external peer-reviewed grant funding for breast cancer research.
Our continued expansion of clinical and research excellence, ongoing recruitment efforts, and the enduring commitment of philanthropists will lead us to better medical treatment for patients and a potential breast cancer cure.
Breast Cancer Clinic
The Braman Family Breast Cancer Institute at Sylvester has evolved greatly since its inception. Our multidisciplinary breast cancer care team has comprehensive experience with a variety of breast health problems, including breast cancer of all stages. The Braman Institute’s impact on the health of our community is significant: last year alone, the Breast Cancer Clinic had more than 9,000 follow-up visits and more than 1,100 new patients.
Breast cancer patient care at the Braman Family Breast Cancer Institute at Sylvester is under the direction of Stefan Glück, M.D. The clinic setting has been reorganized to better meet the needs of our rapidly growing patient population. Today, expert nurses and a multidisciplinary team of breast cancer specialists provide patient consultations at one centralized location. Specially trained patient care coordinators work to navigate and facilitate everything from referrals to clinical trials, so our patients and their families can focus their energy on healing.
The Breast Cancer Clinic is located on the second floor of Sylvester Comprehensive Cancer Center/UMHC – University of Miami Hospital & Clinics in Miami.
Breast Cancer Clinic Goals
- To expeditiously and considerately offer comprehensive diagnosis and treatment services to breast cancer patients
- To improve patient treatment outcomes and conduct clinical research in order to create new knowledge leading to better and safer therapies, as well as vital new options for breast cancer patients; to provide an educational venue for medical students, house staff, and fellows
Breast Cancer Clinical Trials
Clinical trials personnel at the Braman Institute specifically attend to the needs of study patients and can be a good resource for patients participating in clinical trials. These professionals also are charged with presenting clinical trials to potential patients and obtaining informed consents and required study procedures. For more information on current breast cancer clinical trials, access our Clinical Trials Matching Service.
Plans for Expansion
As we continue to expand and serve more patients each year, Sylvester is working with a team of architects to design and build a new breast cancer clinic. The new four-story addition to the existing building will triple the size of our current facility. The new breast cancer clinic facility will house a state-of-the-art stereotactic radiosurgery system, called CyberKnife, which is an alternative to surgery that uses targeted beams of radiation to destroy tumors. Plans also include an integrated breast health clinic designed for more efficient patient care. The second and third floors will feature three fully functioning operating rooms for breast surgery, a conference room, as well as administrative and oncologists’ offices.
Clinical research scientists at the Braman Institute are spearheading clinical trials in areas such as: breast cancer genetics, prevention, imaging, preoperative therapy, new surgical techniques, postsurgical chemotherapy, and radiation. In addition, new research is underway to improve mammography screening. Learn more about clinical research at the Braman Institute.
The Braman Institute’s team of social scientists study patient risks and behaviors to optimize breast cancer care. One such study is focused on breast cancer patients in different ethnic communities to better understand how to educate our culturally diverse population regarding breast cancer screening, access to care, and to improve early diagnosis. Learn more about social sciences at the Braman Institute.
Molecular scientists at the Braman Institute work to understand the molecular pathways that cause breast cancer growth and treatment resistance. Research areas include cell cycle/signaling, signaling/structure, transcriptional regulation, breast development models, tumor immunology/pathology and experimental therapeutics. Learn more about molecular sciences at the Braman Institute.